$2.76 Billion is the total value of Tekla Capital Management LLC's 116 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Sell | Gilead Sciences, Inc. | $243,495,000 | +8.8% | 2,079,731 | -8.8% | 8.81% | -0.6% |
| CELG | Sell | Celgene Corporation | $223,280,000 | -2.9% | 1,929,234 | -3.3% | 8.08% | -11.3% |
| BIIB | Buy | Biogen Inc. | $142,685,000 | -0.5% | 353,233 | +4.1% | 5.16% | -9.1% |
| MYL | Buy | Mylan NVshares euro | $124,659,000 | +107.9% | 1,837,005 | +81.9% | 4.51% | +89.9% |
| VRTX | Buy | Vertex Pharmaceuticals, Inc. | $110,873,000 | +102.4% | 897,903 | +93.4% | 4.01% | +84.8% |
| ALXN | Buy | Alexion Pharmaceuticals plc | $105,625,000 | +21.3% | 584,305 | +16.3% | 3.82% | +10.8% |
| AGN | New | Allergan plcshares | $104,295,000 | – | 343,686 | +100.0% | 3.77% | – |
| REGN | Regeneron Pharmaceuticals, Inc. | $95,479,000 | +13.0% | 187,166 | 0.0% | 3.45% | +3.2% | |
| INCY | Sell | Incyte Corporation | $91,753,000 | +6.9% | 880,461 | -6.0% | 3.32% | -2.4% |
| JNJ | Buy | Johnson & Johnson | $86,214,000 | +97.2% | 884,612 | +103.5% | 3.12% | +80.1% |
| TEVA | Buy | Teva Pharmaceutical Industries Ltd.adr | $82,007,000 | +32.0% | 1,387,594 | +39.1% | 2.97% | +20.5% |
| AMGN | Buy | Amgen Inc. | $76,342,000 | +35.8% | 497,280 | +41.4% | 2.76% | +24.0% |
| BMRN | BioMarin Pharmaceutical Inc. | $73,174,000 | +9.8% | 534,977 | 0.0% | 2.65% | +0.2% | |
| ALKS | Buy | Alkermes plcshares | $66,622,000 | +85.7% | 1,035,470 | +76.0% | 2.41% | +69.5% |
| PFE | Pfizer, Inc. | $54,930,000 | -3.6% | 1,638,241 | 0.0% | 1.99% | -12.0% | |
| ILMN | Buy | Illumina, Inc. | $50,144,000 | +102.7% | 229,641 | +72.4% | 1.81% | +85.1% |
| AET | Aetna, Inc. | $42,308,000 | +19.6% | 331,931 | 0.0% | 1.53% | +9.3% | |
| AKRXQ | Akorn, Inc. | $37,088,000 | -8.1% | 849,482 | 0.0% | 1.34% | -16.1% | |
| BMY | Bristol-Myers Squibb Co. | $35,615,000 | +3.2% | 535,240 | 0.0% | 1.29% | -5.8% | |
| CTRX | Catamaran Corporation | $26,484,000 | +2.6% | 433,600 | 0.0% | 0.96% | -6.4% | |
| ENDP | Buy | Endo International PLCshares | $25,956,000 | +14.9% | 325,873 | +29.4% | 0.94% | +4.9% |
| MOH | Molina Healthcare, Inc. | $24,457,000 | +4.5% | 347,901 | 0.0% | 0.88% | -4.6% | |
| MDRX | Allscripts Healthcare Solutions, Inc. | $24,326,000 | +14.4% | 1,778,200 | 0.0% | 0.88% | +4.4% | |
| RCPT | Receptos, Inc. | $23,718,000 | +15.3% | 124,800 | 0.0% | 0.86% | +5.3% | |
| ACOR | Acorda Therapeutics, Inc. | $22,693,000 | +0.2% | 680,862 | 0.0% | 0.82% | -8.6% | |
| AMGN | New | Amgen Inc.call | $22,414,000 | – | 146,000 | +100.0% | 0.81% | – |
| BAX | Baxter International, Inc. | $22,350,000 | +2.1% | 319,600 | 0.0% | 0.81% | -6.7% | |
| HUM | New | Humana, Inc. | $21,423,000 | – | 112,000 | +100.0% | 0.78% | – |
| IBB | Ishares Nasdaq Biotechnology ETFetf | $21,278,000 | +7.4% | 57,670 | 0.0% | 0.77% | -1.9% | |
| JAZZ | Sell | Jazz Pharmaceuticals plcshares | $21,191,000 | +1.6% | 120,357 | -0.3% | 0.77% | -7.3% |
| HCA | Buy | HCA Holdings, Inc. | $19,395,000 | +74.8% | 213,788 | +45.0% | 0.70% | +59.5% |
| VTR | Ventas Inc. | $18,179,000 | -15.0% | 292,782 | 0.0% | 0.66% | -22.3% | |
| NBIX | Sell | Neurocrine Biosciences, Inc. | $17,951,000 | -9.8% | 375,860 | -25.0% | 0.65% | -17.7% |
| PRTK | New | Paratek Pharmaceuticals, Inc. | $17,807,000 | – | 691,000 | +100.0% | 0.64% | – |
| DOC | Physicians Realty Trust | $16,142,000 | -12.8% | 1,050,902 | 0.0% | 0.58% | -20.3% | |
| IPXL | Impax Laboratories, Inc. | $15,828,000 | -2.0% | 344,683 | 0.0% | 0.57% | -10.5% | |
| Corsicanto Ltd.note 3.5% 1/15/32 | $15,803,000 | +0.9% | 14,700,000 | 0.0% | 0.57% | -7.7% | ||
| ALR | Alere, Inc. | $15,714,000 | +7.9% | 297,901 | 0.0% | 0.57% | -1.4% | |
| ACAD | New | ACADIA Pharmaceuticals Inc. | $15,496,000 | – | 370,000 | +100.0% | 0.56% | – |
| MCK | McKesson Corporation | $15,256,000 | -0.6% | 67,862 | 0.0% | 0.55% | -9.2% | |
| MPW | Medical Properties Trust Inc. | $15,123,000 | -11.1% | 1,153,574 | 0.0% | 0.55% | -18.8% | |
| OHI | Omega Healthcare Investors Inc. | $14,182,000 | -15.4% | 413,116 | 0.0% | 0.51% | -22.7% | |
| HRTX | Sell | Heron Therapeutics, Inc. | $13,616,000 | +7.1% | 436,970 | -50.0% | 0.49% | -2.2% |
| CYH | Community Health Systems, Inc. | $13,197,000 | +20.5% | 209,572 | 0.0% | 0.48% | +9.9% | |
| KPTI | Karyopharm Therapeutics Inc. | $12,978,000 | -11.1% | 476,966 | 0.0% | 0.47% | -18.8% | |
| ALNY | Sell | Alnylam Pharmaceuticals, Inc. | $12,406,000 | -8.7% | 103,495 | -20.5% | 0.45% | -16.7% |
| ESPR | New | Esperion Therapeutics, Inc.call | $12,100,000 | – | 148,000 | +100.0% | 0.44% | – |
| ESPR | New | Esperion Therapeutics, Inc. | $12,100,000 | – | 148,000 | +100.0% | 0.44% | – |
| CI | Cigna Corporation | $12,029,000 | +25.2% | 74,251 | 0.0% | 0.44% | +14.2% | |
| HCNPRI | Health Care REIT Inc. | $11,888,000 | -11.5% | 200,000 | 0.0% | 0.43% | -19.2% | |
| SYK | Stryker Corporation | $11,845,000 | +3.6% | 123,940 | 0.0% | 0.43% | -5.3% | |
| STJ | St Jude Medical, Inc. | $11,802,000 | +11.7% | 161,510 | 0.0% | 0.43% | +1.9% | |
| SBRA | Sabra Health Care REIT Inc. | $11,742,000 | -22.4% | 456,190 | 0.0% | 0.42% | -29.0% | |
| MYL | New | Mylan NVcall | $11,699,000 | – | 172,400 | +100.0% | 0.42% | – |
| TXMD | TherapeuticsMD, Inc. | $11,645,000 | +29.9% | 1,481,500 | 0.0% | 0.42% | +18.6% | |
| TMO | Sell | Thermo Fisher Scientific Inc. | $11,211,000 | -41.1% | 86,395 | -39.0% | 0.41% | -46.2% |
| ZBH | Zimmer Biomet Holdings, Inc. | $11,174,000 | -7.1% | 102,300 | 0.0% | 0.40% | -15.1% | |
| PIRS | New | Pieris Pharmaceuticals, Inc. | $10,583,000 | – | 3,848,191 | +100.0% | 0.38% | – |
| MRK | Merck & Co., Inc. | $10,532,000 | -1.0% | 185,000 | 0.0% | 0.38% | -9.5% | |
| EARS | New | Auris Medical Holding AG | $10,400,000 | – | 2,105,263 | +100.0% | 0.38% | – |
| SGNT | Sagent Pharmaceuticals, Inc. | $9,955,000 | +4.6% | 409,500 | 0.0% | 0.36% | -4.5% | |
| LTC | LTC Properties Inc. | $9,843,000 | -9.6% | 236,618 | 0.0% | 0.36% | -17.4% | |
| CNC | Centene Corporation | $9,648,000 | +13.7% | 120,000 | 0.0% | 0.35% | +3.9% | |
| THC | Buy | Tenet Healthcare Corporation | $9,521,000 | +223.2% | 164,500 | +176.5% | 0.34% | +194.0% |
| VSTM | Verastem, Inc. | $9,424,000 | -25.9% | 1,249,827 | 0.0% | 0.34% | -32.3% | |
| IRWD | Ironwood Pharmaceuticals, Inc. | $9,263,000 | -24.6% | 768,050 | 0.0% | 0.34% | -31.2% | |
| ALQA | New | Alliqua BioMedical, Inc. | $8,696,000 | – | 1,650,000 | +100.0% | 0.32% | – |
| IDXX | Buy | IDEXX Laboratories, Inc. | $8,489,000 | -2.3% | 132,352 | +135.2% | 0.31% | -10.8% |
| ELGX | Endologix Inc. | $8,452,000 | -10.1% | 551,000 | 0.0% | 0.31% | -18.0% | |
| SNH | Senior Housing Properties Trustshares | $8,417,000 | -20.9% | 479,604 | 0.0% | 0.30% | -27.7% | |
| WCG | WellCare Health Plans Inc. | $7,520,000 | -7.3% | 88,652 | 0.0% | 0.27% | -15.3% | |
| ITCI | Buy | Intra-Cellular Therapies, Inc. | $7,258,000 | +102.6% | 227,164 | +51.4% | 0.26% | +85.2% |
| MACK | Merrimack Pharmaceuticals, Inc. | $7,021,000 | +4.1% | 567,787 | 0.0% | 0.25% | -4.9% | |
| BLUE | Sell | bluebird bio, Inc. | $6,885,000 | +4.6% | 40,895 | -25.0% | 0.25% | -4.6% |
| Supernus Pharmaceuticals, Inc.note 7.50% 5/1/19 | $6,655,000 | +37.9% | 2,000,000 | 0.0% | 0.24% | +26.2% | ||
| ZGNX | Buy | Zogenix, Inc. | $6,385,000 | +63.5% | 3,800,811 | +33.3% | 0.23% | +49.0% |
| MDVN | New | Medivation, Inc | $6,133,000 | – | 53,700 | +100.0% | 0.22% | – |
| MDVN | New | Medivation, Inccall | $6,133,000 | – | 53,700 | +100.0% | 0.22% | – |
| RARE | New | Ultragenyx Pharmaceutical Inc. | $6,143,000 | – | 60,000 | +100.0% | 0.22% | – |
| THC | New | Tenet Healthcare Corporationcall | $6,077,000 | – | 105,000 | +100.0% | 0.22% | – |
| HCA | New | HCA Holdings, Inc.call | $6,015,000 | – | 66,300 | +100.0% | 0.22% | – |
| ENDP | New | Endo International PLCcall | $5,902,000 | – | 74,100 | +100.0% | 0.21% | – |
| ISIS | New | Isis Pharmaceuticals, Inc. | $5,651,000 | – | 98,200 | +100.0% | 0.20% | – |
| ISIS | New | Isis Pharmaceuticals, Inc.call | $5,651,000 | – | 98,200 | +100.0% | 0.20% | – |
| AGNPRA | New | Allergan plcpreferred convertible | $5,213,000 | – | 5,000 | +100.0% | 0.19% | – |
| ACHN | Achillion Pharmaceuticals Inc | $4,849,000 | -10.1% | 547,300 | 0.0% | 0.18% | -18.2% | |
| EPZM | Epizyme, Inc. | $4,800,000 | +27.8% | 200,000 | 0.0% | 0.17% | +16.8% | |
| Spectrum Pharmaceuticals, Inc.note 2.75% 12/15/18 | $4,694,000 | +2.7% | 5,000,000 | 0.0% | 0.17% | -6.1% | ||
| FOMX | New | Foamix Pharmaceuticals Ltd.shares | $4,241,000 | – | 413,800 | +100.0% | 0.15% | – |
| KYTH | KYTHERA Biopharmaceuticals Inc. | $4,196,000 | +50.2% | 55,717 | 0.0% | 0.15% | +36.9% | |
| T107PS | Wright Medical Group Inc. | $4,099,000 | +1.8% | 156,100 | 0.0% | 0.15% | -7.5% | |
| FLKS | Flex Pharma, Inc. | $4,001,000 | -12.2% | 232,600 | 0.0% | 0.14% | -19.9% | |
| AEGR | Aegerion Pharmaceuticals, Inc. | $3,908,000 | -27.5% | 206,000 | 0.0% | 0.14% | -34.1% | |
| AXDX | Accelerate Diagnostics, Inc. | $3,733,000 | +14.7% | 144,625 | 0.0% | 0.14% | +4.7% | |
| Merrimack Pharmaceuticals, Inc.note 4.50% 7/15/20 | $3,113,000 | +6.3% | 1,485,000 | 0.0% | 0.11% | -2.6% | ||
| New | TetraLogic Pharmaceuticals Corporationnote 8.00% 6/15/19 | $2,658,000 | – | 4,500,000 | +100.0% | 0.10% | – | |
| MYGN | Myriad Genetics, Inc. | $2,542,000 | -4.0% | 74,800 | 0.0% | 0.09% | -12.4% | |
| BDSI | BioDelivery Sciences International, Inc. | $1,990,000 | -24.2% | 250,000 | 0.0% | 0.07% | -30.8% | |
| GNMK | New | GenMark Diagnostics, Inc. | $1,949,000 | – | 215,149 | +100.0% | 0.07% | – |
| DERM | New | Dermira, Inc. | $1,706,000 | – | 97,197 | +100.0% | 0.06% | – |
| CLLS | Cellectis S.A.sponsored ads | $1,443,000 | +4.3% | 40,000 | 0.0% | 0.05% | -5.5% | |
| New | Trillium Therapeutics Inc. | $1,418,000 | – | 65,000 | +100.0% | 0.05% | – | |
| BLCM | Bellicum Pharmaceuticals, Inc. | $1,276,000 | -8.2% | 60,000 | 0.0% | 0.05% | -16.4% | |
| ABAX | New | Abaxis, Inc. | $1,157,000 | – | 22,466 | +100.0% | 0.04% | – |
| SAGE | Sage Therapeutics, Inc. | $1,095,000 | +45.4% | 15,000 | 0.0% | 0.04% | +33.3% | |
| IPCI | Sell | IntelliPharmaceutics International Inc. | $1,041,000 | -73.2% | 354,047 | -74.6% | 0.04% | -75.3% |
| GLPG | New | Galapagos NVsponsored adr | $1,030,000 | – | 20,000 | +100.0% | 0.04% | – |
| SGMO | Sell | Sangamo BioSciences, Inc. | $832,000 | -92.2% | 75,000 | -89.0% | 0.03% | -92.9% |
| CDTX | New | Cidara Therapeutics, Inc. | $701,000 | – | 50,000 | +100.0% | 0.02% | – |
| MGNX | MacroGenics, Inc. | $484,000 | +21.0% | 12,743 | 0.0% | 0.02% | +12.5% | |
| ADAP | New | Adaptimmune Therapeutics plcsponsored adr | $504,000 | – | 27,500 | +100.0% | 0.02% | – |
| ZFGN | Zafgen, Inc. | $461,000 | -12.5% | 13,307 | 0.0% | 0.02% | -19.0% | |
| XNCR | Xencor, Inc. | $439,000 | +43.5% | 20,000 | 0.0% | 0.02% | +33.3% | |
| KITE | Sell | Kite Pharma, Inc. | $384,000 | -85.7% | 6,300 | -86.5% | 0.01% | -86.8% |
| OGXI | OncoGenex Pharmaceuticals, Inc. | $264,000 | +8.6% | 113,100 | 0.0% | 0.01% | 0.0% | |
| ABBV | Sell | AbbVie Inc. | $10,000 | -100.0% | 156 | -100.0% | 0.00% | -100.0% |
| SRPT | Exit | Sarepta Therapeutics, Inc.call | $0 | – | -115,100 | -100.0% | -0.06% | – |
| SRNE | Exit | Sorrento Therapeutics, Inc. | $0 | – | -142,597 | -100.0% | -0.06% | – |
| EBIO | Exit | Eleven Biotherapeutics, Inc. | $0 | – | -195,964 | -100.0% | -0.07% | – |
| IMMU | Exit | Immunomedics, Inc. | $0 | – | -500,000 | -100.0% | -0.08% | – |
| CYH | Exit | Community Health Systems, Inc.call | $0 | – | -50,000 | -100.0% | -0.10% | – |
| MYGN | Exit | Myriad Genetics, Inc.call | $0 | – | -74,800 | -100.0% | -0.10% | – |
| KITE | Exit | Kite Pharma, Inc.call | $0 | – | -46,500 | -100.0% | -0.11% | – |
| ATHN | Exit | Athenahealth, Inc.call | $0 | – | -23,100 | -100.0% | -0.11% | – |
| ATHN | Exit | Athenahealth, Inc. | $0 | – | -23,100 | -100.0% | -0.11% | – |
| SRPT | Exit | Sarepta Therapeutics, Inc. | $0 | – | -230,300 | -100.0% | -0.12% | – |
| TROV | Exit | TrovaGene, Inc. | $0 | – | -650,000 | -100.0% | -0.18% | – |
| ACTPRA | Exit | Actavis plcpreferred convertible series a | $0 | – | -5,000 | -100.0% | -0.20% | – |
| INCY | Exit | Incyte Corporationcall | $0 | – | -56,000 | -100.0% | -0.20% | – |
| BIIB | Exit | Biogen Idec, Inc.call | $0 | – | -12,200 | -100.0% | -0.20% | – |
| MNTA | Exit | Momenta Pharmaceuticals, Inc. | $0 | – | -353,575 | -100.0% | -0.21% | – |
| ACHN | Exit | Achillion Pharmaceuticals Inc.call | $0 | – | -547,300 | -100.0% | -0.21% | – |
| ILMN | Exit | Illumina, Inc.call | $0 | – | -29,400 | -100.0% | -0.22% | – |
| ALNY | Exit | Alnylam Pharmaceuticals, Inc.call | $0 | – | -54,300 | -100.0% | -0.22% | – |
| INFI | Exit | Infinity Pharmaceuticals, Inc. | $0 | – | -438,623 | -100.0% | -0.24% | – |
| ARAY | Exit | Accuray, Inc. | $0 | – | -731,943 | -100.0% | -0.27% | – |
| GEVA | Exit | Synageva BioPharma Corpcall | $0 | – | -71,000 | -100.0% | -0.27% | – |
| AGIO | Exit | Agios Pharmaceuticals, Inc. | $0 | – | -100,300 | -100.0% | -0.38% | – |
| PRGO | Exit | Perrigo Company plccall | $0 | – | -67,700 | -100.0% | -0.44% | – |
| ABBV | Exit | AbbVie Inc.call | $0 | – | -200,000 | -100.0% | -0.46% | – |
| ALXN | Exit | Alexion Pharmaceuticals, Inc.call | $0 | – | -77,200 | -100.0% | -0.53% | – |
| GEVA | Exit | Synageva BioPharma Corp | $0 | – | -198,689 | -100.0% | -0.77% | – |
| PRGO | Exit | Perrigo Company plcshares | $0 | – | -130,652 | -100.0% | -0.86% | – |
| GILD | Exit | Gilead Sciences, Inc.call | $0 | – | -430,100 | -100.0% | -1.67% | – |
| B108PS | Exit | Actavis plcshares | $0 | – | -361,686 | -100.0% | -4.26% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.